Revenue estimates for Standard BioTools Inc (NASDAQ:LAB) have remained steady at $171.20 million for the full year 2024. However, they have declined from $188.17 million to $186.93 million for 2025 ...
LAB is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of LAB shares has held flat since the market last closed. This is a 0.00% change.
Astera Labs is positioned to address future data center bandwidth and memory bottlenecks with a solid balance sheet and ...
Good day and welcome to the Standard BioTools, Inc., First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EAG, Inc. (Evans Analytical Group), the world’s leading, fully integrated, independent laboratory network, providing high value expert analytical and testing ...
Standard BioTools Inc (NASDAQ:LAB) is set to release its Q1 2025 earnings on May 6, 2025. The consensus estimate for Q1 2025 revenue is $40.10 million, and the earnings are expected to come in at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback